Vi­a­tris plans for Ozem­pic, We­govy gener­ics amid law­suit from No­vo Nordisk over We­govy

Vi­a­tris Phar­ma­ceu­ti­cals’ ap­pli­ca­tions for gener­ic op­tions for type 2 di­a­betes drug Ozem­pic and weight loss drug We­govy are now un­der reg­u­la­to­ry re­view, ac­cord­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER